Technology
Health
Biotechnology

Champions Oncology

$8.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.57 (-6.34%) As of 2:26 PM EDT today
-$0.57 (-6.34%) Today

Why Robinhood?

You can buy or sell CSBR and other stocks, options, ETFs, and crypto commission-free!

About CSBR

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Read More It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Employees
92
Headquarters
Hackensack, New Jersey
Founded
1985
Market Cap
104.40M
Price-Earnings Ratio
1.57K
Dividend Yield
0.00
Average Volume
118.08K
High Today
$8.99
Low Today
$7.70
Open Price
$8.99
Volume
55.80K
52 Week High
$17.90
52 Week Low
$5.98

Collections

Technology
Health
Biotechnology
Cancer Prevention
Pharmaceutical
US
North America

CSBR Earnings

-$0.01
$0.01
$0.03
$0.05
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
$0.03 per share
Actual
-$0.01 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.